Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Quarterly Statistics, Q1 2009

This article was originally published in Start Up

Executive Summary

Highlights from the Q1 2009 review of start-up dealmaking: Fundraising in the biopharma, medical device, and in vitro diagnostics industries totaled $692 million--a 31% drop from Q1 2008 but a 25% increase from last quarter--with most of the money, $544 million, coming from the biopharma sector. There were no significant acquisitions of biopharma or in vitro diagnostic start-up companies in the first quarter of the year, but device giant Medtronic paid a total of $550 million for two start-ups. Cancer was the most popular therapeutic area for start-up alliances this quarter.

Related Content


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts